Quince Therapeutics (QNCX) is experiencing significant stock volatility after a Form 8-K filing revealed concerns regarding its financial stability. This development follows a temporary stock rally, indicating heightened investor uncertainty, which could affect market sentiment and future performance.
Quince Therapeutics Inc has appointed LifeSci Capital as its exclusive financial advisor, resulting in a surge in its stock price. This strategic move could indicate upcoming corporate activities that may positively influence QNCX's valuation and investor interest.
